China: Commercial health insurance trends

Published on February 27, 2023

While the National Reimbursement Drug List (NRDL) continues to be the dominant path to public reimbursement in China, commercial health insurance (CHI) in China is quickly emerging as an alternative reimbursement option. Its development gained momentum particularly around 2015, driven by government policy support, unmet demand, and supply-side innovations.

City CHI has been one of the fastest-growing categories in the market, driven by a fast rollout, improved coverage, and ongoing optimization over the past three years.

  • Fast rollout: City CHI has rolled out across more than 250 cities in China, with approximately 140 million subscribers currently. Key drivers include affordable annual premiums typically around 200 yuan (renminbi), and strong support from the local government
  • Better coverage: Many city CHI plans offer more comprehensive coverage with better payout ratios, including…

Continue reading on website
Other news

Germany: How the GKV-FinStG law is transforming the pharma P&R landscape

February 27, 2023
In November 2022, the new GKV Financial Stabilization Act (GKV-FinStG) came into effect after being passed by the German parliament. The objective of the law is to financially stabilize German statutory health insurance policies (GKV). To achieve this objective, far-reaching changes in the legal framework for pricing and reimbursement of innovative pharmaceuticals have been adopted. Our industry e

How healthcare payment solutions can evolve to capture patients’ willingness to pay

February 27, 2023
More than two years after COVID-19 forced businesses to accelerate their digital strategy, consumers are permanently evolving their payment preferences in favor of digital formats, and businesses are adapting to consumers’ needs. In 2022, more than 53% of e-commerce merchants expanded payment methods to include digital wallets, QR payments, and digital invoicing.Similar trends can be observed with